Huaren Pharmaceutical Co., Ltd. (300110.SZ)
CNY 3.77
(-0.53%)
CNY 3.77
(-0.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.63 Billion | 1.61 Billion | 1.56 Billion | 1.31 Billion | 1.46 Billion | 1.38 Billion |
| Cost of Revenue | 937.2 Million | 918.71 Million | 771.34 Million | 752.34 Million | 634.03 Million | 586.5 Million |
| Gross Profit | 699.05 Million | 700.78 Million | 789.5 Million | 564.25 Million | 827.9 Million | 797.35 Million |
| Operating Expenses | 469.88 Million | 392.92 Million | 482.15 Million | 388.04 Million | 666.66 Million | 689.6 Million |
| Selling, General and Administrative Expenses | 262.24 Million | 244.34 Million | 324.84 Million | 258.6 Million | 517.7 Million | 557 Million |
| Research and Development Expenses | 68.68 Million | 55.3 Million | 63.67 Million | 55.21 Million | 62.43 Million | 56.02 Million |
| Other Expenses | 138.96 Million | 7.36 Million | -1.04 Million | -2.4 Million | -6.63 Million | -4.23 Million |
| Cost and Expenses | 1.41 Billion | 1.31 Billion | 1.25 Billion | 1.14 Billion | 1.3 Billion | 1.27 Billion |
| Operating Income | 225.94 Million | 198.49 Million | 151.3 Million | 114.04 Million | 74.04 Million | 47.78 Million |
| Interest Expense | 65.73 Million | 64.16 Million | 63.13 Million | 10.95 Million | 22.31 Million | 36.91 Million |
| Income Tax Expense | 37.08 Million | 24.52 Million | 16.2 Million | 14.74 Million | 22.24 Million | 6.09 Million |
| Earnings before Tax | 230.51 Million | 205.85 Million | 150.25 Million | 111.63 Million | 67.4 Million | 43.55 Million |
| Net Income | 188.06 Million | 180.77 Million | 130.4 Million | 94.62 Million | 42.06 Million | 38.79 Million |
| Earnings Per Share Basic | 0.16 | 0.15 | 0.11 | 0.08 | 0.04 | 0.03 |
| Earnings Per Share Diluted | 0.16 | 0.15 | 0.11 | 0.08 | 0.04 | 0.03 |
| Weighted Average Shares Outstanding | 1.18 Billion | 1.18 Billion | 1.18 Billion | 1.18 Billion | 1.18 Billion | 1.15 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.18 Billion | 1.18 Billion | 1.18 Billion | 1.18 Billion | 1.18 Billion | 1.15 Billion |
| Gross Margin | 0.43 | 0.43 | 0.51 | 0.43 | 0.57 | 0.58 |
| EBIT Margin | 0.26 | 0.29 | 0.28 | 0.22 | 0.19 | 0.16 |
| Profit Margin | 0.11 | 0.11 | 0.08 | 0.07 | 0.03 | 0.03 |
| EBITDA | 431.65 Million | 419.6 Million | 348.33 Million | 236.04 Million | 206.1 Million | 196.82 Million |
| Earnings Before Tax Margin | 0.14 | 0.12 | 0.10 | 0.09 | 0.05 | 0.03 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 297.16 Million | 364.75 Million | 400.46 Million | 1.63 Billion | 420.32 Million | 386.88 Million |
| Cost of Revenue | 205.86 Million | 244.47 Million | 235.72 Million | 937.2 Million | 254.3 Million | 203.47 Million |
| Gross Profit | 91.3 Million | 120.28 Million | 164.73 Million | 699.05 Million | 166.02 Million | 183.4 Million |
| Operating Expenses | 51.47 Million | 79.69 Million | 93.22 Million | 393.07 Million | 97.97 Million | 88.88 Million |
| Selling, General and Administrative Expenses | 36.77 Million | 25.75 Million | 73.61 Million | - | -5.69 Million | 112.4 Million |
| Research and Development Expenses | 14.7 Million | 16.71 Million | 18.16 Million | - | 25.25 Million | 14.86 Million |
| Other Expenses | - | -237.33 Thousand | -1.45 Million | 4.57 Million | 2.1 Million | 182.88 Thousand |
| Cost and Expenses | 257.34 Million | 324.16 Million | 328.95 Million | 1.33 Billion | 352.27 Million | 292.35 Million |
| Operating Income | 39.82 Million | 29.67 Million | 71.5 Million | 225.94 Million | 71.19 Million | 66.31 Million |
| Interest Expense | 13.14 Million | 12.28 Million | 15.25 Million | 61.51 Million | 14.12 Million | 15.18 Million |
| Income Tax Expense | 3.52 Million | 5.09 Million | 5.32 Million | 37.08 Million | 20.52 Million | 10.28 Million |
| Earnings before Tax | 27.27 Million | 29.43 Million | 57.69 Million | 230.51 Million | 73.3 Million | 66.49 Million |
| Net Income | 22.31 Million | 22.39 Million | 50.82 Million | 188.06 Million | 50.97 Million | 54.8 Million |
| Earnings Per Share Basic | 0.02 | 0.02 | 0.04 | - | 0.04 | 0.05 |
| Earnings Per Share Diluted | 0.02 | 0.02 | 0.04 | - | 0.04 | 0.05 |
| Weighted Average Shares Outstanding | 1.18 Billion | 1.18 Billion | 1.18 Billion | 1.18 Billion | 1.18 Billion | 1.18 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.18 Billion | 1.18 Billion | 1.18 Billion | 1.18 Billion | 1.18 Billion | 1.18 Billion |
| Gross Margin | 0.31 | 0.33 | 0.41 | 0.43 | 0.39 | 0.47 |
| EBIT Margin | 0.14 | 0.11 | 0.21 | - | 0.17 | 0.24 |
| Profit Margin | 0.08 | 0.06 | 0.13 | 0.11 | 0.12 | 0.14 |
| EBITDA | 40.42 Million | 38.45 Million | 83.24 Million | - | 72.31 Million | 93.3 Million |
| Earnings Before Tax Margin | 0.13 | 0.08 | 0.18 | 0.14 | 0.17 | 0.17 |
DPUM
GGPS3
HKMPY
TUPY3
SHIEF
AURUM